Quantitative Net Water Uptake as a Predictor of Functional Outcomes After Intravenous Thrombolysis in Acute Ischemic Stroke International Multicenter Observational Retrospective Study
No Interventions: Not applicable as this is an observational, retrospective study.
Study summary
While the effectiveness of intravenous thrombolysis (IVT) decreases over time, patients show considerable variability in how quickly their ischemic core progresses. Quantitative net water uptake (NWU) has emerged as a biomarker indicating blood-brain barrier disruption and may better reflect the "tissue clock" than time alone. Low NWU is associated with favorable outcomes, whereas high NWU predicts poor outcomes and futile recanalization. The study aims to determine whether NWU measured on initial non-contrast CT is a treatment effect modifier for the IVT therapy.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Acute ischemic stroke treated with intravenous thrombolysis
* Imaging with non-contrast cranial CT on admission
* Follow-up imaging with non-contrast cranial CT or MRI 12-24 hours after IVT
* Final Infarct volume \> 5ml
* ASPECTS available
Exclusion Criteria:
* Known use of oral anticoagulation (OAC) on admission
* Preexisting ischemic infarction on admission non-contrast cranial CT
* Patients with large vessel occlusion AIS who underwent mechanical thrombectomy
* Low imaging quality precluding radiological measurements
* Severe white matter lesions precluding radiological measurements
* No ASPECTS
Primary outcome measure(s)
Number of participants with functional independence (modified Rankin Scale score 0-1) — at 90 days Functional independence defined as a modified Rankin Scale (mRS) score of 0-1 assessed at 90 days.
Trial sites (1)
Facility
City
Region
Status
Department of Neurology, St. John's Hospital, Vienna, Austria, Vienna, 1020
Vienna
Austria
Recruiting
More Sigmund Freud PrivatUniversitat trials in Austria
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.